Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients

PHASE3UnknownINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions

Liver Transplant Recipient

Interventions

DRUG

micafungin

Micafungin 100 mg/day intravenous (2.0 mg/kg/day in subjects weighing \<40 kg)

DRUG

Fluconazole

Fluconazole 100\~200mg/day, IV care until oral medication becomes possible

Trial Locations (1)

RECRUITING

Asan Medical Center, Seoul